PARTIAL METABOLIC CLEARANCES AS DETERMINANTS OF THE ORAL BIOAVAILABILITY OF PROPRANOLOL

被引:31
作者
WALLE, T [1 ]
WALLE, UK [1 ]
OLANOFF, LS [1 ]
CONRADI, EC [1 ]
机构
[1] MED UNIV S CAROLINA,DEPT MED,CHARLESTON,SC 29425
关键词
D O I
10.1111/j.1365-2125.1986.tb02893.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:317 / 323
页数:7
相关论文
共 28 条
[21]  
WALLE T, 1978, CLIN PHARMACOL THER, V24, P668
[22]   SIMULTANEOUS DETERMINATION OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL IN PLASMA BY MASS FRAGMENTOGRAPHY [J].
WALLE, T ;
MORRISON, J ;
WALLE, K ;
CONRADI, E .
JOURNAL OF CHROMATOGRAPHY, 1975, 114 (02) :351-359
[23]  
WALLE T, 1978, CLIN CHEM, V24, P991
[24]  
WALLE T, 1979, CLIN PHARMACOL THER, V26, P548
[25]  
WALLE T, 1979, CLIN PHARMACOL THER, V26, P686
[26]   BIOLOGIC DETERMINANTS OF PROPRANOLOL DISPOSITION - RESULTS FROM 1308 PATIENTS IN THE BETA-BLOCKER HEART-ATTACK TRIAL [J].
WALLE, T ;
BYINGTON, RP ;
FURBERG, CD ;
MCINTYRE, KM ;
VOKONAS, PS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :509-518
[27]   DIRECT MEASUREMENT OF PROPRANOLOL BIOAVAILABILITY DURING ACCUMULATION TO STEADY-STATE [J].
WOOD, AJJ ;
CARR, K ;
VESTAL, RE ;
BELCHER, S ;
WILKINSON, GR ;
SHAND, DG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (04) :345-350
[28]  
Ziegler DM., 1980, ENZYMATIC BASIS DETO, VI, P201